Antigenemia guided ganciclovir therapy in allogeneic BMT recipients: Pre-emptive or early treatment of established CMV disease?

被引：0
|
作者：
Machado, CM
Boas, LSV
Dulley, FL
Macedo, MC
Massumoto, C
Castelli, JB
Medeiros, RS
Silva, RL
Pannuti, CS
机构：
[1] UNIV SAO PAULO,SCH MED,DISCIPLINE HEMATOL,HEMOCTR SAO PAULO,FDN PROSANGUE,SAO PAULO,BRAZIL
[2] UNIV SAO PAULO,SCH MED,DISCIPLINE INFECT DIS,SAO PAULO,BRAZIL
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1684 / 1684
页数：1
相关论文
共 50 条
  • [1] CMV pneumonia in allogeneic BMT recipients undergoing early treatment or pre-emptive ganciclovir therapy
    CM Machado
    FL Dulley
    LSVilas Boas
    JB Castelli
    MCA Macedo
    RL Silva
    R Pallota
    RS Saboya
    CS Pannuti
    Bone Marrow Transplantation, 2000, 26 : 413 - 417
  • [2] CMV pneumonia in allogeneic BMT recipients undergoing early treatment or pre-emptive ganciclovir therapy
    Machado, CM
    Dulley, FL
    Boas, LSV
    Castelli, JB
    Macedo, MCA
    Silva, RL
    Pallota, R
    Saboya, RS
    Pannuti, CS
    BONE MARROW TRANSPLANTATION, 2000, 26 (04) : 413 - 417
  • [3] Prevention of CMV disease in allogeneic BMT recipients by cytomegalovirus antigenemia-guided preemptive ganciclovir therapy
    Koehler, M
    StGeorge, K
    Ehrlich, GD
    Mirro, J
    Neudorf, SM
    Rinaldo, C
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (01) : 43 - 47
  • [4] Comparison of the efficacy and cost effectiveness of pre-emptive therapy as directed by CMV antigenemia and prophylaxis with ganciclovir in lung transplant recipients
    Kelly, J
    Hurley, D
    Raghu, G
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (04): : 355 - 359
  • [5] Comparison of CMV Antigenemia (Ag) and PCR during Pre-Emptive Therapy Monitoring and Treatment of CMV Disease
    Doucette, Karen
    Venner, Jeffery
    Preiksaitis, Jutta
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 143 - 143
  • [6] Comparison of the efficacy and cost-effectiveness of pre-emptive therapy as directed by CMV antigenemia and prophylaxis with ganciclovir in lung transplant recipients
    Weill, D
    Zamora, MR
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (08): : 815 - 816
  • [7] The pattern of CMV reactivation in allogeneic transplant recipients treated with pre-emptive therapy
    Farah, N.
    McCue, J.
    Sawhney, H.
    Lasa, M.
    Atkins, M.
    Szydlo, R.
    Apperley, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S298 - S299
  • [8] Ganciclovir pre-emptive therapy for cytomegalovirus antigenemia in a pemphigus vulgaris patient
    Shibata, Akitaka
    Yoshikawa, Takenori
    Makita, Sumiko
    Takami, Norito
    Matsuzaki, Takuro
    Sugiyama, Yutaka
    Akiyama, Masashi
    JOURNAL OF DERMATOLOGY, 2019, 46 (11): : E423 - E424
  • [9] Increased transplant related morbidity and mortality in CMV seropositive patients despite efficacious prevention of CMV disease by pre-emptive therapy with ganciclovir after allogeneic BMT.
    Broers, A
    Van Esser, J
    Henzen-Logmans, S
    Kuenen-Boumeester, V
    van der Holt, B
    Löwenberg, B
    Cornelissen, JJ
    BLOOD, 1998, 92 (10) : 281A - 281A
  • [10] Transplant related mortality following allogeneic BMT in CMV seropositive donor/recipient pairs is increased despite efficacious prevention of CMV disease by pre-emptive therapy with ganciclovir
    Broers, A
    Henzen-Logmans, S
    Kuenen-Boumeester, V
    de la Riviére, GB
    Van der Holt, B
    Löwenberg, B
    Cornelissen, JJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 13 - 13
12345